Walgreens in talks for sale to PE firm: WSJ
Walgreens is weighing a potential sale to a private equity firm, according to a report in The Wall Street Journal....
Anthem faces backlash from new anesthesia policy, reverses course in all states
A recent decision from Anthem Blue Cross Blue Shield in three states to stop paying for anesthesia care in select...
Bristol Myers Squibb latest drug company to sue HHS over 340B rebate model
Bristol Myers Squibb became the latest large drugmaker to sue the federal government over a plan to change how it...
Are there lessons to be learned from primary care stumbles?
Just three years ago, primary care was a hot category with major players making sizeable investments to build out healthcare...
New study finds 137M people are eligible for GLP-1s
Amid ongoing concerns about the cost and supply of GLP-1s, a new study suggests that a wide swath of American...
Trump could boost Medicare Advantage—but reform may be coming
Medicare Advantage (MA) insurer stocks soared following Election Day, with healthcare onlookers assuming the new Trump administration would set favorable...
Planned Parenthood decries executive power in pending House bill
National healthcare groups have signed on in opposition to a House bill that would soon grant President Donald Trump the...
High labor costs challenge hospitals
Though hospital performance has remained relatively stable, high labor costs continue to challenge hospitals’ bottom line, according to September figures...
DOJ sues to block UnitedHealth’s $3.3B acquisition of Amedisys
The Department of Justice (DOJ) filed suit Tuesday to block UnitedHealth’s $3.3 billion acquisition of home health company Amedisys, arguing...
Cencora to buy Retina Consultants of America in $4.6B deal
Drug distributor Cencora plans to buy Retina Consultants of America from Webster Equity Partners in a $4.6 billion deal. RCA...
